The carbohydrate moiety of factor V modulates inactivation by activated protein C

Blood

Volumn 89, Issue 12, 1997, Pages 4348-4354

  Fernández, José A ^a   Hackeng, Tilman M ^a   Kojima, Kazuhisa ^a   Griffin, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ASPARAGINE LINKED OLIGOSACCHARIDE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; GLUCAN SYNTHASE; PROCOAGULANT; SIALIDASE; THROMBIN;

ARTICLE; DEGLYCOSYLATION; ELECTROPHORETIC MOBILITY; ENZYME INACTIVATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOSIS;

EID: 1842326190     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4348     Document Type: Article

References (33)

1. Kane W, Davie E: Blood coagulation factor V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539, 1988
2. Kane WH, Ichinose A, Hagen FS, Davie EW: Cloning of cDNA's coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 26:6508, 1987
3. Pittman DD, Tomkinson KN, Kaufman RJ: Post-translational requirements for functional factor V and factor VIII secretion in mammalian cells. J Biol Chem 269:17329, 1994
4. Kane WH, Majerus PW: Purification and characterization of human coagulation factor V. J Biol Chem 256:1002, 1981
5. Pittman DD, Tomkinson KN, Michnick D, Selighsohn U, Kaufman RJ: Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity. Biochemistry 33:6952, 1994
6. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG: Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846, 1987
7. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869, 1994
8. R506Q by activated protein C. J Biol Chem 270:21158, 1995
9. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
10. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
11. Greengard JS, Sun X, Xu X, Fernández JA, Griffin JH, Evatt B: Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343:1361, 1994
12. 506 of factor V. Lancet 343:1535, 1994
13. Sun X, Evatt B, Griffin JH: Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83:3120, 1994
14. Griffin JH, Evatt B, Wideman C, Fernández JA: Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989, 1993
15. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina R: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503, 1993
16. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
17. Zöller B, Svensson PJ, He X, Dahlbäck B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 94:2521, 1994
18. 506-factor V. Blood 85:3405, 1995
19. 506Q. J Biol Chem 270:4053, 1995
20. 506 → glutamine mutation. Stroke 27:1163, 1996
21. van den Eijnden DH, Joziasse DH: Enzymes associated with glycosylation. Curr Opin Struct Biol 3:711, 1993
22. Opdenakker G, Rudd PM, Ponting CP, Dwek RA: Concepts and principles of glycobiology. FASEB J 7:1330, 1993
23. Rasmussen J: Effect of glycosylation on protein function. Curr Opin Struct Biol 2:682, 1992
24. Hackeng TM, van't Veer C, Meijers JCM, Bouma BN: Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 269:21051, 1994
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
26. Guinto ER, Esmon CT, Mann KG, MacGillivray RTA: The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 267:2971, 1992
27. Bruin T, Sturk A, ten Cate JW, Cath M: The function of the human factor V carbohydrate moiety in blood coagulation. Eur J Biochem 170:305, 1987
28. Gumprecht JG, Colman RW: Roles of sialic acid in the function of bovine factor V. Arch Biochem Biophys 169:278, 1975
29. Bharadwaj D, Harris RJ, Kisiel W, Smith KJ: Enzymatic removal of sialic acid from human factor IX and factor X has no effect on their coagulant activity. J Biol Chem 270:6537, 1995
30. Colucci M, Ciavarella N, Giliberti MG, Semeraro N: Resistance to activated protein C (APC): Influence of factor V levels. Thromb Haemost 72:985, 1994
31. Rosing J, Bakker H, Christella M, Thomassen L, Hemker H, Tans G: Characterization of two forms of human factor Va with different cofactor activities. J Biol Chem 268:21130, 1993
32. Remold-O'Donnell E, Rosen FS: Proteolytic fragmentation of sialophorin (CD43): Localization of the activation-inducing site and examination of the role of sialic acid. J Immunol 145:3372, 1990
33. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP: Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 74:449, 1995